Gloria M. Gager

658 total citations
14 papers, 273 citations indexed

About

Gloria M. Gager is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Gloria M. Gager has authored 14 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Gloria M. Gager's work include Diabetes Treatment and Management (4 papers), Acute Myocardial Infarction Research (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Gloria M. Gager is often cited by papers focused on Diabetes Treatment and Management (4 papers), Acute Myocardial Infarction Research (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Gloria M. Gager collaborates with scholars based in Austria, Poland and United States. Gloria M. Gager's co-authors include Jolanta M. Siller‐Matula, Marek Postuła, Bernd Jilma, Ceren Eyileten, Christian Hengstenberg, Dirk von Lewinski, Harald Sourij, Georg Gelbenegger, Poonam Velagapudi and Christina Kronberger and has published in prestigious journals such as European Heart Journal, Clinical Pharmacology & Therapeutics and Biomedicine & Pharmacotherapy.

In The Last Decade

Gloria M. Gager

14 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gloria M. Gager Austria 8 153 84 66 63 48 14 273
Marcello Ravani Italy 10 172 1.1× 48 0.6× 61 0.9× 72 1.1× 47 1.0× 27 296
Marco Spartera Italy 9 283 1.8× 52 0.6× 27 0.4× 68 1.1× 34 0.7× 20 358
Deshan Yuan China 9 109 0.7× 47 0.6× 85 1.3× 86 1.4× 21 0.4× 35 233
R Tantillo Italy 11 174 1.1× 107 1.3× 58 0.9× 70 1.1× 26 0.5× 18 335
Daniél V. Møller Denmark 7 216 1.4× 41 0.5× 20 0.3× 41 0.7× 81 1.7× 14 341
Hans Hillege Netherlands 7 224 1.5× 30 0.4× 42 0.6× 27 0.4× 38 0.8× 13 296
Anna Borowiec Poland 9 129 0.8× 30 0.4× 27 0.4× 77 1.2× 61 1.3× 35 299
Yubi Lin China 11 230 1.5× 19 0.2× 44 0.7× 81 1.3× 78 1.6× 23 339
Giovanni Bertero Italy 11 239 1.6× 52 0.6× 16 0.2× 68 1.1× 50 1.0× 28 382
Mehmet Mustafa Tabakçı Türkiye 10 207 1.4× 51 0.6× 51 0.8× 82 1.3× 18 0.4× 24 314

Countries citing papers authored by Gloria M. Gager

Since Specialization
Citations

This map shows the geographic impact of Gloria M. Gager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gloria M. Gager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gloria M. Gager more than expected).

Fields of papers citing papers by Gloria M. Gager

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gloria M. Gager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gloria M. Gager. The network helps show where Gloria M. Gager may publish in the future.

Co-authorship network of co-authors of Gloria M. Gager

This figure shows the co-authorship network connecting the top 25 collaborators of Gloria M. Gager. A scholar is included among the top collaborators of Gloria M. Gager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gloria M. Gager. Gloria M. Gager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Jarosz-Popek, Joanna, Ceren Eyileten, Gloria M. Gager, et al.. (2023). The interaction between non-coding RNAs and SGLT2: A review. International Journal of Cardiology. 398. 131419–131419. 2 indexed citations
2.
Gager, Gloria M., Ceren Eyileten, Marek Postuła, et al.. (2023). Expression Patterns of MiR-125a and MiR-223 and Their Association with Diabetes Mellitus and Survival in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome. Biomedicines. 11(4). 1118–1118. 4 indexed citations
3.
Gager, Gloria M., Ceren Eyileten, Marek Postuła, et al.. (2022). Association Between the Expression of MicroRNA-125b and Survival in Patients With Acute Coronary Syndrome and Coronary Multivessel Disease. Frontiers in Cardiovascular Medicine. 9. 948006–948006. 8 indexed citations
4.
Gelbenegger, Georg, Juergen Grafeneder, Gloria M. Gager, et al.. (2022). Advanced pharmacodynamics of cangrelor in healthy volunteers: a dose-finding, open-label, pilot trial. Thrombosis Journal. 20(1). 19–19. 4 indexed citations
5.
Bogyi, Matthias, Rüdiger Schernthaner, Christian Loewe, et al.. (2021). Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions. 14(24). 2643–2656. 76 indexed citations
6.
Hofer, Felix, Thomas Perkmann, Gloria M. Gager, et al.. (2021). Comparison of high-sensitivity C-reactive protein vs. C-reactive protein for diagnostic accuracy and prediction of mortality in patients with acute myocardial infarction. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 58(4). 342–349. 7 indexed citations
7.
Gelbenegger, Georg, Christian Schoergenhofer, Bernd Jilma, et al.. (2021). Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta‐Analysis. Clinical Pharmacology & Therapeutics. 110(2). 424–431. 6 indexed citations
8.
Gager, Gloria M., Georg Gelbenegger, Bernd Jilma, et al.. (2021). Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-Analysis. Frontiers in Cardiovascular Medicine. 8. 691907–691907. 34 indexed citations
9.
Gager, Gloria M., Dirk von Lewinski, Harald Sourij, et al.. (2021). Effects of SGLT2 Inhibitors on Ion Homeostasis and Oxidative Stress associated Mechanisms in Heart Failure. Biomedicine & Pharmacotherapy. 143. 112169–112169. 47 indexed citations
10.
Grafeneder, Juergen, Christian Schörgenhofer, Georg Gelbenegger, et al.. (2021). The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trial. Haematologica. 107(9). 2121–2132. 28 indexed citations
11.
Gager, Gloria M., Georg Gelbenegger, Bernd Jilma, et al.. (2021). Cardiovascular outcome in patients treated with SGLT2 inhibitors for heart failure: a meta-analysis. European Heart Journal. 42(Supplement_1). 1 indexed citations
12.
Gager, Gloria M., Bernd Jilma, Max‐Paul Winter, et al.. (2020). Ticagrelor and prasugrel are independent predictors of improved long‐term survival in ACS patients. European Journal of Clinical Investigation. 50(11). e13304–e13304. 9 indexed citations
13.
Gager, Gloria M., Felix Hofer, Max‐Paul Winter, et al.. (2020). Interleukin-6 level is a powerful predictor of long-term cardiovascular mortality in patients with acute coronary syndrome. Vascular Pharmacology. 135. 106806–106806. 45 indexed citations
14.
Unseld, Matthias, et al.. (2019). Patients’ attitude and knowledge towards resuscitation and advance care planning at the palliative care unit. European Journal of Cancer Care. 28(5). e13109–e13109. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026